-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Conference Background: Guiding Unit:
Organizer: Organizer:
[Time]
[Location]
[Form]
[Meeting Scale] The
scope of participation of the participants has been determined The schedule of the speaker meeting
September 22 morning | The main venue | ||
09:15-09:30 | The opening speech of the leaders of the park | ||
09:30-10:00 | Opportunities and challenges for the development of biopharmaceuticals in China | ||
10:00-10:30 | The latest progress in the development of biological drugs | ||
10:30-11:00 | coffee break, visit the exhibition | ||
11:00-11:30 | Relevant regulatory requirements for biotech drug quality research | ||
11:30-12:00 | Current Opportunities and Challenges of Biopharmaceutical CMC | ||
12:00-13:30 | lunch break | ||
September 22 pm | Topic 1 Vaccine development and evaluation | ||
13:30-14:00 | Research and development of high-efficiency new crown antibody vaccine | ||
14:00-14:30 | Key Problems and Countermeasures of Efficient Industrialized Production of Virus Vaccines | ||
14:30-15:00 | Vaccine process validation and regulatory points | ||
15:00-15:30 | coffee break, visit the exhibition | ||
15:30-16:00 | Application and prospect of artificial intelligence in mRNA vaccine design | ||
16:00-16:30 | Vaccine upstream and downstream production technology and quality control | ||
16:30-17:00 | Overall design and development of mRNA vaccines | ||
16:30-17:00 | Key points of innovative development of broad-spectrum coronavirus vaccine | ||
September 23rd morning | Topic 2 Biopharmaceutical R&D Technology | ||
09:00-09:30 | Research progress of antiviral therapeutic antibodies | ||
09:30-10:00 | Development of Novel Antibody Conjugates | ||
10:00-10:20 | coffee break, visit the exhibition | ||
10:20-10:50 | Antibody Mass Production-Analysis of Cell Culture Process | ||
10:50-11:20 | The importance of QBD from antibody design to industrial production | ||
11:20-11:50 | Key points and case analysis of pharmaceutical research and development of monoclonal antibodies | ||
12:00-13:30 | Conference lunch | ||
September 23rd afternoon | Topic 3 Biopharmaceutical R&D Technology | Branch venue | |
13:30-14:00 | Research progress of antibody drug quality control | ||
14:00-14:30 | Application of Antibody Drugs in the Treatment of Tumors and Infectious Diseases | ||
14:30-15:00 | coffee break, visit the exhibition | ||
15:00-15:30 | Process optimization strategies in the process of technology transfer | ||
15:30-16:00 | Bispecific antibody drug development technology | ||
16:00-16:30 | the end of the conference |
com